NATtrol Bacteriophage MS2 Launched by ZeptoMetrix
ZeptoMetrix, an Antylia Scientific company, launches the NATtrol Bacteriophage MS2 quantitative stock: NATMS2-STQ.
Read MorePosted by Chris Wolski | Nov 21, 2022 | Controls, Molecular Diagnostics |
ZeptoMetrix, an Antylia Scientific company, launches the NATtrol Bacteriophage MS2 quantitative stock: NATMS2-STQ.
Read MorePosted by Chris Wolski | Nov 21, 2022 | Covid 19 |
Researchers have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood.
Read MorePosted by Andy Lundin | Nov 17, 2022 | Molecular Diagnostics |
DiaSorin received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Simplexa Congenital CMV Direct kit.
Read MorePosted by Chris Wolski | Nov 16, 2022 | Lab Management |
With the year almost over, CLP Editor Chris Wolski spends some time looking back at the big events of 2022.
Read MorePosted by Chris Wolski | Nov 14, 2022 | Diagnostic Technologies |
Clinical laboratory experts predict continued importance on COVID testing, ongoing technician shortages, and more in 2023.
Read More